Literature DB >> 10937869

The role of heterotrimeric G proteins in platelet activation.

S Offermanns1.   

Abstract

Activation of platelets plays a central role in hemostasis as well as in various thromboembolic diseases like myocardial infarction or stroke. Most platelet activating stimuli function through receptors which couple to heterotrimeric G proteins of the Gi, Gq and G12 families. Recent studies have elucidated the roles of individual G proteins in the regulation of platelet functions like shape change, aggregation and granule secretion. The signaling pathways mediated by heterotrimeric G proteins operate synergistically to induce a full activation of platelets. This review summarizes recent progress in the understanding of upstream regulation of platelet activation through G protein-coupled receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10937869     DOI: 10.1515/BC.2000.051

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  12 in total

1.  Impaired activation of murine platelets lacking G alpha(i2).

Authors:  H M Jantzen; D S Milstone; L Gousset; P B Conley; R M Mortensen
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  The effect of platelet G proteins on platelet extravasation and tumor growth in the murine model of ovarian cancer.

Authors:  Min Soon Cho; Jiasong Li; Ricardo Gonzalez-Delgado; Hani Lee; Matthew Vasquez; Tiancheng He; Yunjie He; Kai Liu; Tomoyuki Sasano; Bernd Nürnberg; Anil K Sood; Stephen T C Wong; Vahid Afshar-Kharghan
Journal:  Blood Adv       Date:  2021-04-13

3.  C-type lectin like receptor 2 (CLEC-2) signals independently of lipid raft microdomains in platelets.

Authors:  Bhanu Kanth Manne; Rachit Badolia; Carol A Dangelmaier; Satya P Kunapuli
Journal:  Biochem Pharmacol       Date:  2014-11-20       Impact factor: 5.858

4.  Regulation and functional consequences of ADP receptor-mediated ERK2 activation in platelets.

Authors:  Analia Garcia; Haripriya Shankar; Swaminathan Murugappan; Soochong Kim; Satya P Kunapuli
Journal:  Biochem J       Date:  2007-06-01       Impact factor: 3.857

5.  Mechanism of activation and functional role of protein kinase Ceta in human platelets.

Authors:  Yamini S Bynagari; Bela Nagy; Florin Tuluc; Kamala Bhavaraju; Soochong Kim; K Vinod Vijayan; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2009-03-13       Impact factor: 5.157

6.  Interaction of G alpha(12) with G alpha(13) and G alpha(q) signaling pathways.

Authors:  Jennifer L Gu; Stefan Müller; Valeria Mancino; Stefan Offermanns; Melvin I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-20       Impact factor: 11.205

7.  Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.

Authors:  Toshio Uemura; Tomihisa Kawasaki; Masatoshi Taniguchi; Yumiko Moritani; Kazumi Hayashi; Tetsu Saito; Jun Takasaki; Wataru Uchida; Keiji Miyata
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

8.  Constitutional chromothripsis involving the critical region of 9q21.13 microdeletion syndrome.

Authors:  Rita Genesio; Paolo Fontana; Angela Mormile; Alberto Casertano; Mariateresa Falco; Anna Conti; Adriana Franzese; Enza Mozzillo; Lucio Nitsch; Daniela Melis
Journal:  Mol Cytogenet       Date:  2015-12-18       Impact factor: 2.009

9.  Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo.

Authors:  Bernhard Nieswandt; Markus Moser; Irina Pleines; David Varga-Szabo; Sue Monkley; David Critchley; Reinhard Fässler
Journal:  J Exp Med       Date:  2007-12-17       Impact factor: 14.307

10.  Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation.

Authors:  Sarah Jones; Katherine L Tucker; Tanya Sage; William J Kaiser; Natasha E Barrett; Philip J Lowry; Andreas Zimmer; Stephen P Hunt; Michael Emerson; Jonathan M Gibbins
Journal:  Blood       Date:  2007-09-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.